Assessing the efficacy, safety and utility of closed- loop insulin delivery compared with sensor- augmented pump therapy in very young children with type 1 diabetes (kidsap02 study): an open- label, multicentre, multinational, randomised cross- over study protocol

HIGHLIGHTS

• who: Malgorzata E Wilinska and colleagues from the Diabetes management in very young children remains challengingGlycaemic targets are achieved at the expense of high parental diabetes management burden and frequent hypoglycaemia, impacting quality of life for the whole family. Our objective is to assess whether automated insulin delivery can improve glycaemic control and alleviate the burden of diabetes management in this particular age group. Methods and analysis The study adopts an open-u00adlabel, multinational, multicentre, randomised, crossover design and aims to randomise , children aged, years with type , diabetes on insulin pump therapy. Following screening, participants will receive . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.